Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in young children with JIA
NCT00775437Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2009
- Primary completion
- Mar 2013
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in polyarticular juvenile idiopathic arthritis, sponsored by AbbVie Inc.. Started Mar 2009; status: completed.
02
Drugs
03
Conditions
polyarticular juvenile idiopathic arthritis
Beyond the preview
Go deeper on NCT00775437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775437.